WELL Health Technologies (TSE:WELL) Price Target Raised to C$7.00 at Scotiabank

WELL Health Technologies (TSE:WELL) had its target price hoisted by Scotiabank from C$6.00 to C$7.00 in a research note issued to investors on Monday,BayStreet.CA reports.

A number of other equities research analysts have also recently commented on WELL. Haywood Securities increased their target price on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. Ventum Financial decreased their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. Finally, CIBC lifted their price objective on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th.

WELL Health Technologies Stock Down 1.3 %

Shares of TSE WELL opened at C$7.00 on Monday. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. The firm’s 50-day moving average is C$5.29 and its two-hundred day moving average is C$4.75. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$7.19. The company has a market capitalization of C$1.74 billion, a PE ratio of 12.28, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.